Sequenom Announces Participation At Two Upcoming Investor Conferences

    Sequenom Announces Participation At Two Upcoming Investor Conferences

PR Newswire

SAN DIEGO, Nov. 6, 2012

SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative diagnostic testing and genetic analysis
solutions, today announced the Company's participation at the upcoming Lazard
Capital Markets 9^th Annual Healthcare Conference in New York and the
Jefferies 2012 Global Healthcare Conference in London. 

On Tuesday, November 13, Harry F. Hixson Jr., Ph.D., Sequenom's Chief
Executive Officer, will present at the Lazard Capital Markets 9^th Annual
Healthcare Conference, starting at 9:30 am ET to provide an overview of and
update on the Company. Then, on Thursday, November 15, Dr. Hixson will present
at the Jefferies 2012 Global Healthcare Conference, starting at 2:20 pm GMT.

Both presentations are expected to last approximately 30 minutes and will be
webcast live through the "Investors" section of the Sequenom website at
www.sequenom.com. Audio replays will be available for 30 days following the
initial presentation webcasts. 

About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a Web site at http://www.sequenom.com to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
Web site to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the Web site.

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)

SOURCE Sequenom, Inc.

Website: http://www.sequenom.com
Contact: Marcy Graham, Senior Director, Investor Relations & Corp Comm,
Sequenom, Inc., +1-858-202-9028, mgraham@sequenom.com; or Media, Jakob
Jakobsen, Chandler Chicco Agency, +1-310-309-1003,
jjakobsen@chandlerchiccocompanies.com
 
Press spacebar to pause and continue. Press esc to stop.